NL-OMON31665尚未招募3 期
Antiplatelet therapy in combination with Recombinant t-PA Thrombolysis in Ischemic Stroke - ARTIS-Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* patients with an acute ischemic stroke receiving rt-PA thrombolysis
- •* age * 18 years
- •* written informed consent is obtained
排除标准
- •* known APT in the previous 5 days(in case of uncertainty the patient may be included)
- •* known thrombocytopenia (thrombocyte count * 100 * 10E9/l)
- •* known contra-indications to ASA treatment (e.g. previous adverse reaction to ASA)
- •* Known anticoagulans usage in the previous 5 days
- •* known legal incompetence of the patient prior to this stroke
研究者
相似试验
进行中（未招募）
不适用
Antiplatelet therapy in combination with Recombinant t-PA Thrombolysis in Ischemic Stroke - ARTISPatients with ischemic strokeMore specific patients with ischemic stroke treated with rt-PA thrombolysisEUCTR2006-006829-13-NLetherlands Heart Foundation1,000
已完成
不适用
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery DiseaseJPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
进行中（未招募）
不适用
ACUTE-PRASJPRN-jRCTs031220079Fujimoto Shigeru200
招募中
不适用
OPTIMA-AF trialPatients with non-valvular Atrial Fibrillation and Ischemic Heart DiseaseNon-valvular atrial fibrillationischemic heart diseaseoral anticoagulantantiplatelet therapy.JPRN-jRCTs051190053Sakata Yasushi1,090
招募中
不适用
Dual-AntiPlatelet Therapy strategies FOR elective PCI in a REAL-world settingNL-OMON51842Amsterdam UMC1,462